The potential impact of male circumcision on HIV in Sub-Saharan AfricaErasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant TuberculosisZika Virus as a Cause of Neurologic DisordersModeling infectious disease dynamics in the complex landscape of global healthCost effectiveness analysis of strategies for tuberculosis control in developing countries.Controlling the last known cluster of Ebola virus disease - Liberia, January-February 2015Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence.Zika Virus and the Guillain–Barré Syndrome — Case Series from Seven CountriesA world of cities and the end of TB.Best practices for sharing information through data platforms: establishing the principlesData sharing in public health emergencies: a call to researchersZika: the origin and spread of a mosquito-borne virusEbola virus disease in West Africa--the first 9 months of the epidemic and forward projectionsGlobal incidence of multidrug-resistant tuberculosisSlow elimination of multidrug-resistant tuberculosisThe population dynamics and control of tuberculosisExposure Patterns Driving Ebola Transmission in West Africa: A Retrospective Observational StudyNutrition, diabetes and tuberculosis in the epidemiological transitionTransmission of Multidrug-Resistant and Drug-Susceptible Tuberculosis within Households: A Prospective Cohort StudyPlanning to improve global health: the next decade of tuberculosis controlZika Virus Infection and Associated Neurologic Disorders in BrazilUniversal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical modelProspects for Tuberculosis EliminationHeterogeneities in the case fatality ratio in the West African Ebola outbreak 2013–2016After 2015: infectious diseases in a new era of health and development.What is the limit to case detection under the DOTS strategy for tuberculosis control?Public health. A National Tuberculosis Archive.Alcohol use as a risk factor for tuberculosis - a systematic review.Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection--a quantitative review.Lives saved by Global Fund-supported HIV/AIDS, tuberculosis and malaria programs: estimation approach and results between 2003 and end-2007.HIV burden in men who have sex with men: a prospective cohort study 2007-2012Highly active antiretroviral treatment for the prevention of HIV transmission.WHO's reply to 'Cholera in the time of War: implications of weak surveillance in Syria for the WHO's preparedness-a comparison of two monitoring systemsCombining domestic and foreign investment to expand tuberculosis control in China.Exploratory analysis of the association between new-type drug use and sexual transmission of HIV in China.Worldwide incidence of malaria in 2009: estimates, time trends, and a critique of methodsNational and international policies to mitigate disease threatsAntiretroviral therapy for tuberculosis control in nine African countries.Health in financial crises: economic recession and tuberculosis in Central and Eastern Europe.HIV treatment as prevention: debate and commentary--will early infection compromise treatment-as-prevention strategies?
P50
Q21144704-E437D596-88B9-4721-BDB7-4D77219C20E7Q22695813-1C9C7464-B20D-4064-AB07-83E6539C9903Q24261288-d80d26f4-4ce6-a047-a8cb-ce9e77a47685Q24277713-2D81DF92-CB76-4B43-9C16-29EB036B5011Q24538952-A601DA7C-9395-4BB0-902E-25F216966F2FQ25018004-505024C6-9E0F-4C8A-8693-DF155A1BAC09Q25255728-AAB65FBD-56CC-4DFC-AED6-641A1709ED41Q26732180-c9814635-473b-d7b1-26a8-fe918e423b1fQ26765397-B86D88CB-270D-4D84-B150-9EDA3A92BCACQ27469125-46094428-9C55-4FFB-952C-EE8241C1FC9EQ27469138-E5CBA859-D55C-4640-99FD-F1B2D5D719CFQ27469144-2199DD51-DC3E-4826-881D-0A7768ABD5A9Q28248431-48B26025-F523-409D-A609-2E342B6FCEA4Q28252480-DE1EB6AE-FE2C-471A-B133-0D5ECE9A947FQ28278696-748891C3-E694-4EE0-A838-A58235578B09Q28282446-CE093C5B-5759-4D15-BCE3-8FD236ADE4DFQ28394360-11314A24-55DD-441D-B36F-90CF10D0E2B9Q28478661-EE7BE50E-6BF6-42BA-B48B-812C1AFC36FCQ28548584-08244810-5224-4E4E-822F-49A97237640CQ28755534-7C39837D-F6D7-4021-9BCD-77F281C8A10BQ29051432-2E8B3A96-8DB1-4826-84E0-D5B274480314Q29305377-2D17D9CB-725C-4C57-9C62-4C92E6FB7982Q29392153-2709122C-1C9E-48EC-86EA-75BA62BF2711Q30251101-260C5C6B-5B5D-4826-9922-41743B599578Q30391463-493E23EE-4397-4F86-A1F0-9FA79C21FE50Q30935500-759D2DBF-86D3-4234-948C-6858A9A24059Q33235346-00E940C1-B1C0-4CDF-B145-852233F189DEQ33360105-AB9745E7-4683-42CA-9174-8670B531124DQ33470290-0AA8753D-9CC9-4A24-84FA-3397595F74E9Q33569197-B30FA491-8958-4F0B-9855-9049F3DAEE7AQ33569510-631BBD9B-64A0-4C8C-9809-3F3B607338C8Q33657373-EF147CFA-9532-435E-88C4-9B526F3A104EQ33699450-D24430D3-2DF6-4430-A6B6-8E5E3A771D4DQ33761064-DABF3C8C-FBFF-4970-94F2-0C969DEB1399Q33777337-3027464C-7A75-4D5A-AE81-FAAD78D5522CQ34113458-D7C1C294-7E35-48F3-BC4C-2C52DF9096FAQ34299007-5416BB5F-8356-4A56-89A1-F5326DC6B084Q34320245-98C5F327-6C79-4A64-A62E-B907680B6102Q34333232-7496EBDE-65DE-4D3E-AF30-51FE18508C02Q34339450-F44C9A20-53BF-4FC6-85B8-F10D04F0AB3C
P50
description
British WHO official
@en
Brits onderzoeker
@nl
name
Christopher Dye
@ast
Christopher Dye
@de
Christopher Dye
@en
Christopher Dye
@es
Christopher Dye
@fr
Christopher Dye
@nl
Christopher Dye
@sl
type
label
Christopher Dye
@ast
Christopher Dye
@de
Christopher Dye
@en
Christopher Dye
@es
Christopher Dye
@fr
Christopher Dye
@nl
Christopher Dye
@sl
prefLabel
Christopher Dye
@ast
Christopher Dye
@de
Christopher Dye
@en
Christopher Dye
@es
Christopher Dye
@fr
Christopher Dye
@nl
Christopher Dye
@sl
P214
P244
P101
P108
P1153
34770166000
P19
P2070
christopher-dye-11370
P21
P213
0000 0000 3551 7123
P214
P244
P31
P463
P496
0000-0002-2957-1793
P569
1956-04-15T00:00:00Z
P735
P7859
lccn-n94801820